Skip to main content

Table 3 KRAS mutation status in the pancreatic juice samples as determined by deep sequencing

From: Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma

  1. aLow-abundance KRAS mutations with a VAF < 3% are specified in red color. NM, no mutation
  2. bNA, not assayed by the PNA clamp method
  3. cKRAS-negative and BRAF-positive tumor. No BRAF p.V600E mutation was detected in the corresponding juice sample (23,266 reads at the locus)
  4. dSample had both c.183A > T and c.183A > C mutations, both corresponding to p.Q61H